OverviewSymptoms of low testosterone can vary considerably, particularly by age and how severe it is.What is low testosterone (male hypogonadism)?
Low testosterone (male hypogonadism) is a condition in which your testicles dont produce enough testosterone (the male sex hormone). Testicles are the gonads (sex organs) in people assigned male at birth (AMAB). More specifically, the Leydig cells in your testicles make testosterone.
Low testosterone causes different symptoms at different ages. Testosterone levels in adults AMAB naturally decline as they age. This includes cisgender men, non-binary people AMAB and transgender women who arent undergoing feminizing hormone therapy.
Other names for low testosterone and male hypogonadism include:
Testosterone is the main androgen. It stimulates the development of male characteristics and is essential for sperm production (spermatogenesis). Levels of testosterone are naturally much higher in people assigned AMAB than in people assigned female at birth (AFAB).
In people assigned AMAB, testosterone helps maintain and develop:
Your body usually tightly controls the levels of testosterone in your blood. Levels are typically highest in the morning and decline through the day.
Your hypothalamus and pituitary gland normally control the amount of testosterone your testicles produce and release.
Your hypothalamus releases gonadotropin-releasing hormone (GnRH), which triggers your pituitary gland to release luteinizing hormone (LH). LH then travels to your gonads (testicles or ovaries) and stimulates the production and release of testosterone. Your pituitary also releases follicle-stimulating hormone (FSH) to cause sperm production.
Any issue with your testicles, hypothalamus or pituitary gland can cause low testosterone (male hypogonadism).
The American Urology Association (AUA) considers low blood testosterone to be less than 300 nanograms per deciliter (ng/dL) for adults.
However, some researchers and healthcare providers disagree with this and feel that levels below 250 ng/dL are low. Providers also take symptoms into consideration when diagnosing low testosterone.
Male hypogonadism is a medical condition that can affect people with testicles at any age from birth through adulthood.
Low testosterone is more likely to affect people who:
Its difficult for researchers to estimate how common low testosterone is since different studies have different definitions for low testosterone.
Data suggest that about 2% of people AMAB may have low testosterone. And other studies have estimated that more than 8% of people AMAB aged 50 to 79 years have low testosterone.
Symptoms of low testosterone can vary considerably, particularly by age.
Symptoms that highly suggest low testosterone in adults assigned male at birth include:
Other symptoms of low testosterone in adults AMAB include:
Low testosterone before or during puberty for children assigned male at birth can result in:
There are several possible causes of low testosterone. The two types of male hypogonadism are:
Causes of primary and secondary hypogonadism are also divided into either congenital (at birth) or acquired (developed later in childhood or adulthood).
Primary hypogonadism happens when something is wrong with your testicles that doesnt allow them to make normal levels of testosterone.
Another name for primary hypogonadism is hypergonadotropic hypogonadism. In this type, your pituitary gland produces more luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (known as gonadotropins) in response to low testosterone levels. The high levels of these hormones would normally tell your testicles to produce more testosterone and sperm. However, if you have damaged (most commonly related to prior chemotherapy) or missing testicles, they cant respond to the increased levels of gonadotropins. As a result, your testicles make too little or no testosterone and sperm.
Sometimes in primary hypogonadism testosterone levels are within the normal range and gonadotropins are high. Your specialist will help you understand if you need treatment, even with normal testosterone levels.
Congenital conditions that affect your testicles and can lead to primary hypogonadism include:
Acquired conditions that affect your testicles and can lead to primary hypogonadism include:
Conditions that affect how your hypothalamus and/or pituitary gland cause secondary hypogonadism. This is known as hypogonadotropic hypogonadism because there are low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Those low levels cause decreased testosterone and sperm production.
Congenital conditions that can lead to secondary hypogonadism include:
Acquired conditions that can lead to secondary hypogonadism include:
Late-onset hypogonadism (LOH) is a type of secondary male hypogonadism that results from normal aging. As males age they have a deterioration of hypothalamic-pituitary function and Leydig cell function that decrease testosterone and/or sperm production.
LOH and low testosterone are more common in people AMAB who have Type 2 diabetes, overweight and/or obesity.
In one study, 30% of people AMAB who were overweight had low testosterone, compared to only 6% of those with weight in the normal range. In another study, 25% of people AMAB with Type 2 diabetes had low testosterone, compared to 13% of those without diabetes.
If you have signs and symptoms of low testosterone, a healthcare provider will perform a physical exam. Theyll also ask questions about your medical history, medications you take or have taken, smoking history and any symptoms you currently have. Blood tests may be ordered.
To make a diagnosis, a provider will consider your specific signs, symptoms and any blood test results.
The following tests can help confirm low testosterone and determine the cause:
Healthcare providers treat low testosterone (male hypogonadism) with testosterone replacement therapy. Testosterone replacement therapy has several different forms, including:
You may not be able to receive testosterone replacement therapy if you have a history of the following:
The side effects of testosterone replacement therapy include:
Laboratory abnormalities that can occur with testosterone replacement therapy include:
Healthcare providers and medical researchers dont know how to prevent low testosterone from genetic conditions or damage to your testicles, hypothalamus or pituitary gland.
Lifestyle habits that may help keep testosterone levels normal include:
Theres no one-time fix for low testosterone. However, consistent hormone replacement therapy helps improve sex drive, ease symptoms of depression and increase energy levels for many people assigned male at birth (AMAB) experiencing low testosterone. Treatment may also boost muscle mass and bone density.
The mortality of people AMAB with testosterone deficiency is significantly higher than among people AMAB with normal testosterone levels. But, it is unclear whether replacing testosterone to a normal level reduces that increased mortality. Treatment is largely focused on the treatment of symptoms, not the specific testosterone level.
For congenital hypogonadism in children assigned male at birth, testosterone replacement therapy often helps prevent problems related to delayed puberty.
If youre taking hormone replacement therapy, regular follow-up appointments with a healthcare provider are important.
If youre experiencing symptoms of low testosterone, such as a decrease in sex drive and hot flashes, talk to a healthcare provider. They will evaluate you and may order blood tests.
If your child assigned male at birth isnt showing signs of puberty by the age of 14, talk to their pediatrician.
A note from Cleveland Clinic
Many people shrug off the symptoms associated with low testosterone as an unpleasant part of getting older. But you should address symptoms that interfere with your quality of life. If youre noticing bothersome signs of low testosterone, see a provider and discuss your options for treatment.
More here:
Low Testosterone (Low T): Causes, Symptoms & Treatment - Cleveland Clinic
- Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0% - Yahoo Finance - April 21st, 2024
- Testosterone replacement therapy: Yes or no - MD Anderson Cancer Center - January 6th, 2024
- 5 Best Testosterone Replacement Therapy Services 2023 - Men's Health - January 6th, 2024
- How Much Is Testosterone? The Cost of Replacement Therapy - Hone Health - January 6th, 2024
- Testosterone Replacement Therapy - Department of Urology - January 6th, 2024
- Testosterone Replacement Therapy for Low T - Ageless Men's Health - January 6th, 2024
- Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk - Medriva - January 6th, 2024
- TRAVERSE Trial: Insights into Testosterone Replacement Therapy Safety - BNN Breaking - January 6th, 2024
- Testosterone replacement therapy may not increase risk of prostate cancer among men with hypogonadism - Medical Dialogues - January 6th, 2024
- Testosterone Replacement Therapy (TRT): Is It Right For You? - December 2nd, 2023
- LowTCenter: Men's Health Clinic for Testosterone Replacement - March 28th, 2023
- Testosterone Replacement Therapy for Men | SynergenX - March 28th, 2023
- Male hypogonadism - Diagnosis and treatment - Mayo Clinic - February 6th, 2023
- Testosterone Replacement Therapy (TRT) Experts | Optimale - December 2nd, 2022
- Testosterone Replacement Therapy Clinic - EHormones MD - November 24th, 2022
- Options to Increase Your Testosterone - Healthline - November 16th, 2022
- Masculinizing hormone therapy - Wikipedia - October 29th, 2022
- Testosterone: What It Is and How It Affects Your Health - October 13th, 2022
- Testosterone What It Does And Doesn't Do - Harvard Health - October 13th, 2022
- Cork woman felt like she lost part of herself after going into menopause aged 27 - RSVP Live - October 13th, 2022
- The Global Testosterone Replacement Therapy Market is - October 4th, 2022
- Hypogonadism in Men | Endocrine Society - October 4th, 2022
- The One Thing This Doctor Says Is A Game Changer When It Comes To Hormones And Aging - TravelAwaits - October 4th, 2022
- Shirley Ballas on her difficult experience with menopause - Good Housekeeping - October 4th, 2022
- Foods That Boost Testosterone: 7 Options and How They Work - Healthgrades - October 4th, 2022
- Dr. Roach: Testosterone injections most likely led to severe stroke - Detroit News - October 4th, 2022
- What To Know About Perimenopause, And How To Manage Symptoms Once They Kick In - The Zoe Report - October 4th, 2022
- CORRECTION -- Marius Pharmaceuticals Receives FDA Approval of KYZATREX, an Oral Testosterone Replacement Therapy - GlobeNewswire - September 25th, 2022
- Testosterone replacement therapy - PubMed - September 16th, 2022
- Risks of testosterone replacement therapy in men - PMC - September 16th, 2022
- The Global Testosterone Replacement Therapy Market is expected to grow by $ 402.87 mn during 2022-2026, accelerating at a CAGR of 3.1% during the... - September 16th, 2022
- Testosterone injections most likely led to a very severe stroke - The Independent - September 16th, 2022
- Best DHEA Supplement (2022 Updated) - The Island Now - September 16th, 2022
- Testosterone Replacement Therapy in the Aged Male: Monitoring Patients | IJGM - Dove Medical Press - September 8th, 2022
- ROACH: Testosterone injections most likely led to a very severe stroke - New Castle News - September 8th, 2022
- Perform Your Best With Comprehensive Bloodwork - duPont REGISTRY News - September 8th, 2022
- What I Learned When I Stopped Testosterone Replacement Therapy |... - Cushing's Disease News - August 30th, 2022
- From White Plains Hospital: Feeling the Effects of Man-o-pause? - theLoop - August 30th, 2022
- SARMs Before And After Results Real SARM Results And Users Review In 2022 - Outlook India - August 30th, 2022
- Larry Wheels Stops Using Steroids: "I Am Going To Be On Testosterone Replacement Therapy" Fitness Volt - Fitness Volt - August 22nd, 2022
- Hormone Replacement Therapy for Men: What to Know - Healthline - August 14th, 2022
- Testosterone Replacement Therapy Market Trends, Analysis, Demand and Global Industry Research Report, Region, and Segment Forecasts 2028 - Digital... - August 14th, 2022
- Cycling and HRT: How will it affect me? - Cyclist - August 14th, 2022
- 6 LGBTQ2S+ musicians celebrate the artists who came before them - CBC.ca - August 14th, 2022
- 'I kept thinking I was having a heart attack but it was the perimenopause' - iNews - July 27th, 2022
- Obese women with high intake of vitamin C and B6 associated with lower breast cancer risk cohort study - NutraIngredients-Asia - July 27th, 2022
- Testosterone Replacement Therapy Market | Incredible Possibilities, Growth, Trend, Opportunities Detailed Analysis and Forecast to 2030 Travel... - July 19th, 2022
- Low on the Male Hormone? 5 Effective Ways to Boost It - Times Square Chronicles - July 19th, 2022
- Ostarine MK-2866 | Review, Alternatives,Side Effects and Results-Health News - Firstpost - July 19th, 2022
- Trans teens: We need to be heard, counted. In Michigan, the backlash is harsh - Bridge Michigan - July 19th, 2022
- Testosterone Therapy Improves Erectile Function and Libido in ... - July 11th, 2022
- Low Testosterone and What You Can Do About It - The Epoch Times - July 11th, 2022
- How Long Does It Take to Feel the Benefits of Testosterone Replacement ... - July 3rd, 2022
- TRT Testosterone Replacement Therapy Clinic - Peter Uncaged MD - July 3rd, 2022
- Men have it too - The Hans India - July 3rd, 2022
- New guidelines for menopause care say women should be offered personalised treatment including diet and HRT - iNews - July 3rd, 2022
- Head-To-Head Contrast: Biogen (NASDAQ:BIIB) and Clarus Therapeutics (NASDAQ:CRXT) - Defense World - July 3rd, 2022
- Im a GP heres the truth behind Davina McCalls claims about HRT and dementia... - The Sun - July 3rd, 2022
- How To Spot The Best Clinic For Your Hormone Replacement Therapy - My MMA News.com - June 22nd, 2022
- Testosterone May Aid Memory in Men With Uncontrolled Diabetes - Everyday Health - June 22nd, 2022
- Boyfriend has been secretly taking testosterone tablets and I worry he may go sterile... - The Sun - June 22nd, 2022
- Sex and aging: Overview, stats, and maintaining satisfaction - Medical News Today - June 22nd, 2022
- Once a Taboo Topic, Menopause Is (Finally) Having Its Wellness Moment - Vogue - June 4th, 2022
- Caitlyn Jenner can still hit golf ball nearly 300 yards after transitioning to female - Washington Times - June 4th, 2022
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) Receives $6.88 Consensus PT from Analysts - Defense World - June 4th, 2022
- Juvenile Macular Degeneration Treatment Market Set to Grow According to Forecasts 2020 2030 Industrial IT - Industrial IT - June 4th, 2022
- Testosterone Replacement Therapy Market 2022 to 2028 Global Industry Analysis, Growth, Trends and Forecast Queen Anne and Mangolia News - Queen Anne... - May 15th, 2022
- Being trans and starting HRT - The Advocate - May 15th, 2022
- DHEA Levels and Their Role in Fertility for Functional Medicine Patients - Digital Journal - May 15th, 2022
- LPCN: First Quarter 2022 Financial and Operational Results - Benzinga - May 15th, 2022
- LIPOCINE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - Marketscreener.com - May 15th, 2022
- No, red light therapy isnt a medically approved treatment for increasing testosterone - ABC10.com KXTV - May 2nd, 2022
- Tucker Carlsons answer to masculinitys supposed crisis? Testicle tanning - The Guardian - April 19th, 2022
- Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing - PR Newswire - April 19th, 2022
- Gilbert Gottfrieds myotonic dystrophy: 5 things to know about the rare genetic disorder - cleveland.com - April 19th, 2022
- Lia Thomas started a conversation about transgender rights. It's time we dive into it. - The Emory Wheel - April 19th, 2022
- Who are the teens at the center of the legal fight over Alabamas law banning transgender treatment? - AL.com - April 19th, 2022
- In Venice, a Young Boatman Steers a Course of His Own - The New York Times - April 19th, 2022
- Female athletes are as capable as male athletes | Opinion | kansan.com - The University Daily Kansan - April 19th, 2022
- FDA Approves Oral Testosterone Replacement Therapy for Hypogonadism - Pharmacy Times - April 6th, 2022